Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience

被引:44
|
作者
Vizzielli, Giuseppe [1 ,2 ]
Costantini, Barbara [1 ]
Tortorella, Lucia [1 ]
Petrillo, Marco [1 ]
Fanfani, Francesco [3 ]
Chiantera, Vito [2 ]
Ercoli, Alfredo [4 ]
Iodice, Raffaella [1 ]
Scambia, Giovanni [1 ]
Fagotti, Anna [5 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Gynecol Oncol, I-00168 Rome, Italy
[2] Fdn Res & Care John Paul II, Div Gynecol Oncol, Campobasso, Italy
[3] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy
[4] Abano Terme Hosp, Dept Gynecol, Padua, Italy
[5] Univ Perugia, St Maria Hosp, Div Minimally Invas Gynecol Surg, Terni, Italy
关键词
GYNECOLOGIC-ONCOLOGY-GROUP; PRIMARY PERITONEAL CANCER; EPITHELIAL OVARIAN; CYTOREDUCTIVE SURGERY; FALLOPIAN-TUBE; SURVIVAL; CARCINOMA; TRIAL; DISEASE; IMPACT;
D O I
10.1245/s10434-014-3783-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to investigate whether preoperative laparoscopic evaluation of the dissemination of disease may have an independent impact on survival in advanced epithelial ovarian cancer (AEOC). All AEOC women were submitted to staging laparoscopy before receiving primary debulking surgery (PDS) or neoadjuvant chemotherapy (NACT). All study women received a laparoscopic score (predictive index value [PIV]) and were stratified into three groups based on volume of disease: high tumor load (HTL) for PIV a parts per thousand yen8, intermediate tumor load (ITL) for PIV equal to 6 and 4, and low tumor load (LTL) for PIV < 4. Surgical and survival outcome were evaluated by univariate and multivariate analysis. Among 348 consecutive patients, almost half (48.0 %) had an HTL. Among 165 cases receiving PDS, residual tumor (RT) was as follows: no gross residual in 102 patients (61.8 %); RT a parts per thousand currency sign1 cm in 48 patients (29.1 %) and RT > 1 cm in 15 cases (9.1 %). When stratifying the whole population according to laparoscopic tumor load, the median progression-free survival (PFS) was 33 months for LTL, 18 months for ITL, and 14 months for HTL (p = 0.0001). The median overall survival (OS) with respect to laparoscopic PIV was not reached for LTL, whereas it was 47 months for ITL and 33 months for HTL, respectively (p = 0.0001). At multivariate analysis, tumor load stratified by PIV retained an independent prognostic value on PFS and OS, together with RT and performance status. RT remains an important prognostic factor in patients with AEOC, but tumor dissemination can play a role in determining prognosis in these women.
引用
收藏
页码:3970 / 3977
页数:8
相关论文
共 50 条
  • [1] Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience
    Giuseppe Vizzielli
    Barbara Costantini
    Lucia Tortorella
    Marco Petrillo
    Francesco Fanfani
    Vito Chiantera
    Alfredo Ercoli
    Raffaella Iodice
    Giovanni Scambia
    Anna Fagotti
    [J]. Annals of Surgical Oncology, 2014, 21 : 3970 - 3977
  • [2] Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A Single-Institution Experience and a Review of the Literature
    Loizzi, Vera
    Leone, Luca
    Camporeale, Anna
    Resta, Leonardo
    Selvaggi, Luigi
    Cicinelli, Ettore
    Cormio, Gennaro
    [J]. ONCOLOGY, 2016, 91 (04) : 211 - 216
  • [3] Introduction of Staging Laparoscopy in the Management of Advanced Epithelial Ovarian, Tubal and Peritoneal Cancer: Impact on Prognosis in a Single Institution Experience
    Fagotti, A.
    Vizzielli, G.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Tortorella, L.
    Scambia, G.
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (03) : 144 - 146
  • [4] INTRODUCTION OF STAGING LAPAROSCOPY IN THE MANAGEMENT OF ADVANCED EPITHELIAL OVARIAN, TUBAL AND PERITONEAL CANCER: IMPACT ON PROGNOSIS IN A SINGLE INSTITUTION EXPERIENCE
    Fagotti, A.
    Vizzielli, G.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Tortorella, L.
    Anchora, L. Pedone
    Scambia, G.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [5] Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience
    Fagotti, A.
    Vizzielli, G.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Tortorella, L.
    Scambia, G.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (02) : 341 - 346
  • [6] Characteristics and prognosis of ovarian metastatic tumors: review of a single-institution experience
    Ulker, V.
    Numanoglu, C.
    Alpay, V.
    Akbayir, O.
    Polat, I.
    Gedikbasi, A.
    Akca, A.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (01) : 75 - 78
  • [7] Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)
    Gunturu, Krishna Soujanya
    Thumar, Jaykumar Ranchodbhai
    Hochster, Howard S.
    Stein, Stacey
    Yao, Xiaopan
    Cong, Xiangyu
    Hahn, Carol
    Kaley, Kristin
    Lacy, Jill
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [8] Neoadjuvant chemotherapy for stage III ovarian cancer: A single-institution experience
    Nizam, A.
    Shih, K. K.
    Shan, W.
    Bustamante, B.
    dos Santos, L.
    Frimer, M.
    Menzin, A. W.
    Sakaris, A.
    Whyte, J. S.
    Goldberg, G. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 132 - 133
  • [9] Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience
    Tuinmann, G
    Hegewisch-Becker, S
    Zschaber, R
    Kehr, A
    Schulz, J
    Hossfeld, DK
    [J]. ANTI-CANCER DRUGS, 2004, 15 (06) : 575 - 579
  • [10] Single-institution experience of preoperative chemoradiotherapy for locally advanced gastric cancer
    Pepek, J. M.
    Chino, J. P.
    Willett, C. G.
    Tyler, D. S.
    Uronis, H. E.
    Czito, B. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)